PMID: 7023656Sep 15, 1981Paper

Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases

Cancer
R S NeimanJ M Bennett

Abstract

Granulocytic sarcoma is an uncommon tumor composed of granulocytic precursor cells. Because it occurs in a variety of clinical settings and because the tumor cells are primitive it is frequently unrecognized during life. This presentation details the authors' experience with 61 biopsy-proven granulocytic sarcomas. The patient age range was from 2 to 81 years (mean 48 years). In eight patients the tumors were multiple. Most common sites of involvement were bone, periosteum, soft tissue, lymph node and skin. Twenty-two tumors occurred in 15 patients with no known disease, 26 occurred in 24 patients with a known myeloproliferative disorder, and 13 occurred in 11 patients with proven acute myeloid leukemia. Thirteen of the 15 patients with no known disease developed acute leukemia in from one to 49 months after the biopsy of their tumors (mean 10 months). Most tumors occurring in patients with a known myeloproliferative disorder were associated with blast crisis. The authors' cases displayed a morphologic range from well-differentiated to those tumors that displayed virtually no evidence of differentiation by conventional microscopy. It was therefore not surprising that most tumors were originally diagnosed as lymphoma. Chloro-acet...Continue Reading

References

May 24, 1978·Acta Neuropathologica·J F LlenaE H Feiring
Apr 1, 1977·Cancer·M KrishnamurthyB R Seligman
Jan 1, 1978·Medical and Pediatric Oncology·J B BelascoC W McMillan
Apr 1, 1979·American Journal of Ophthalmology·H D Perry, F J Mallen
Nov 1, 1977·American Journal of Clinical Pathology·E A BrugoO E Pautasso
Feb 1, 1978·Cancer·S B KapadiaR J Hartsock
Nov 1, 1977·Human Pathology·G P Carmichael, Y T Lee
May 1, 1975·Cancer·E A BrugoJ Contanzi
Feb 1, 1975·Journal of Clinical Pathology·D Y Mason, C R Taylor
Jan 1, 1976·Journal of Clinical Pathology·J G Salway
May 1, 1966·Journal of Clinical Pathology·N B BennettD Ogston
Jan 1, 1973·Journal of Clinical Pathology·D Catovsky, D A Galton
Mar 1, 1971·Cancer·S LowenbraunA A Serpick
Jun 1, 1971·British Journal of Haematology·H AsamerH Braunsteiner
May 1, 1969·American Journal of Clinical Pathology·L S Garfinkel, D E Bennett
Sep 1, 1969·Medicine·B A ChabnerG P Canellos
Apr 1, 1967·Cancer·J Laszlo, H E Grode
Feb 1, 1966·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R S BriggsS C Finch
May 1, 1960·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·W C MOLONEYL FLIEGELMAN

❮ Previous
Next ❯

Citations

Aug 1, 1996·Medical and Pediatric Oncology·D K ShahC A Felix
Sep 1, 1996·Diagnostic Cytopathology·P M GirardotP Vielh
Nov 14, 2000·Diagnostic Cytopathology·A OrucevicP Gattuso
Jan 1, 1990·Diagnostic Cytopathology·J F SilvermanW J Frable
Oct 1, 1993·Diagnostic Cytopathology·S S RaabK R Geisinger
Nov 1, 1990·Head & Neck·J S ChoH Goepfert
Jan 1, 1993·Neuroradiology·B J Frohna, D J Quint
Jan 1, 1989·Acta Neuropathologica·T A SimpsonJ C Barton
Jan 1, 1990·Virchows Archiv. A, Pathological Anatomy and Histopathology·C Fellbaum, M L Hansmann
Nov 1, 1989·Indian Journal of Pediatrics·N VarmaG Garewal
Jan 1, 1990·Urologic Radiology·D BlumenthalJ Orr
Feb 24, 2005·Journal of Neurology·Martijn H SmidtMartin J van den Bent
Jul 14, 2005·European Journal of Pediatrics·Yusuke ShiozawaYuichiro Yamashiro
Jun 15, 2007·International Journal of Clinical Oncology·Enrico BalleariRiccardo Ghio
Oct 24, 2008·International Journal of Clinical Oncology·Su Youn LeeJu Hie Lee
May 25, 2007·International Ophthalmology·Kamel HmidiMoncef Khairallah
Oct 13, 2011·Neurocritical Care·G M MalloryG Lanzino
Apr 13, 2011·Hepatology International·Xiao-Feng HangRui-Qi Zhang
Nov 19, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Aurora Rodríguez PérezEduardo Ortiz Cruz
Sep 11, 2010·International Journal of Hematology·Jun ImagawaHironori Harada
Nov 1, 1986·The American Journal of Medicine·B L PowellJ M Sterchi
May 1, 1994·Cancer Genetics and Cytogenetics·P HeimannE Sariban
Jan 1, 1991·Clinical Neurology and Neurosurgery·A MoschB A Kazzaz
Jun 5, 2004·The Breast : Official Journal of the European Society of Mastology·S Dutta RoyS N Selvachandran
Jan 1, 1991·Clinical Radiology·M J LeeE Breatnach
Mar 14, 2003·Surgical Neurology·Sharon W W ChanK W Chan
Nov 1, 1996·Leukemia Research·G SpecchiaV Liso
Jul 15, 1997·Cancer Genetics and Cytogenetics·N P BownM M Reid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.